Literature DB >> 30983500

VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence.

Matthew Randesi1, Wim van den Brink2, Orna Levran1, Peter Blanken2,3, Jan M van Ree4, Jurg Ott5, Mary Jeanne Kreek1.   

Abstract

Aim: To determine if selected serotonergic and noradrenergic gene variants are associated with heroin addiction. Subjects & methods: A total of 126 variants in 19 genes in subjects with Dutch European ancestry from The Netherlands. Subjects included 281 opioid-dependent volunteers in methadone maintenance or heroin-assisted treatment, 163 opioid-exposed but not opioid-dependent volunteers who have been using illicit opioids but never became opioid-dependent and 153 healthy controls.
Results: Nominal associations were indicated for 20 variants in six genes including an experiment-wise significant association from the combined effect of three SLC18A2 SNPs (rs363332, rs363334 and rs363338) with heroin dependence (pfinal = 0.047).
Conclusion: Further studies are warranted to confirm and elucidate the role of these variants in the vulnerability to opioid addiction.

Entities:  

Keywords:  ; VMAT2; association study; case–control; exposed but not dependent; heroin dependence

Year:  2019        PMID: 30983500      PMCID: PMC6566135          DOI: 10.2217/pgs-2018-0137

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  48 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Heroin-assisted treatment in the Netherlands: History, findings, and international context.

Authors:  Peter Blanken; Wim van den Brink; Vincent M Hendriks; Ineke A Huijsman; Marjolein G Klous; Elisabeth J Rook; Jennifer S Wakelin; Cas Barendrecht; Jos H Beijnen; Jan M van Ree
Journal:  Eur Neuropsychopharmacol       Date:  2010-04       Impact factor: 4.600

3.  In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.

Authors:  Rajesh Narendran; Brian J Lopresti; Diana Martinez; Neale Scott Mason; Michael Himes; Maureen A May; Dennis C Daley; Julie C Price; Chester A Mathis; W Gordon Frankle
Journal:  Am J Psychiatry       Date:  2011-10-31       Impact factor: 18.112

Review 4.  Identifying rare variants associated with complex traits via sequencing.

Authors:  Bingshan Li; Dajiang J Liu; Suzanne M Leal
Journal:  Curr Protoc Hum Genet       Date:  2013-07

5.  Neuroendocrine correlates of temperament traits in abstinent opiate addicts.

Authors:  G Gerra; A Zaimovic; M Timpano; U Zambelli; M Begarani; G F Marzocchi; M Ferri; R Delsignore; F Brambilla
Journal:  J Subst Abuse       Date:  2000

6.  S100A10 identified in a genome-wide gene × cannabis dependence interaction analysis of risky sexual behaviours.

Authors:  Renato Polimanti; Shashwath A Meda; Godfrey D Pearlson; Hongyu Zhao; Richard Sherva; Lindsay A Farrer; Henry R Kranzler; Joel Gelernter
Journal:  J Psychiatry Neurosci       Date:  2017-06       Impact factor: 6.186

7.  Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2015-07-31       Impact factor: 2.533

8.  TPH2 and TPH1: association of variants and interactions with heroin addiction.

Authors:  David A Nielsen; Sandra Barral; Dmitri Proudnikov; Scott Kellogg; Ann Ho; Jurg Ott; Mary Jeanne Kreek
Journal:  Behav Genet       Date:  2008-01-08       Impact factor: 2.805

Review 9.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

10.  Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates.

Authors:  G Gerra; L Garofano; G Santoro; S Bosari; C Pellegrini; A Zaimovic; G Moi; M Bussandri; A Moi; F Brambilla; C Donnini
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-04-01       Impact factor: 3.568

View more
  3 in total

1.  Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependence.

Authors:  Matthew Randesi; Orna Levran; Wim van den Brink; Peter Blanken; Jan M van Ree; Jurg Ott; Mary J Kreek
Journal:  Pharmacogenomics       Date:  2020-08-06       Impact factor: 2.533

2.  Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users.

Authors:  Vadim Yuferov; Eduardo R Butelman; Matthew Randesi; Wim van den Brink; Peter Blanken; Jan M van Ree; Mary Jeanne Kreek
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-25       Impact factor: 2.570

Review 3.  The Use of Drosophila to Understand Psychostimulant Responses.

Authors:  Travis James Philyaw; Adrian Rothenfluh; Iris Titos
Journal:  Biomedicines       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.